Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

3 Longevity ETFs to Buy and Hold (and Hold)

The size of the longevity industry could roughly triple in the next decade, and these ETFs may help to provide access to a fast-growing space.

MarketBeat

The Market May Be Missing What’s Changing at BigBear AI

BigBear AI is on track to continue rebounding as its transition to AI powered infrastructure provider to world agencies gains traction.

MarketBeat

CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007’ Risk

CME Group (NASDAQ:CME) Chairman and CEO Terry Duffy sharply criticized the Commodity Futures Trading Commission’s approval of a Bitcoin perpetual futures contract for Kalshi, saying the product does not fit his view of a futures contract and raises risks for retail investors. Speaking at an investo

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Chime Financial CEO Maps Growth Roadmap, $2.7B Revenue Target at Conference

Chime Financial (NASDAQ:CHYM) founder and CEO Chris Britt outlined the digital banking company’s growth strategy, product roadmap and margin targets during a presentation at the William Blair conference, emphasizing Chime’s focus on primary checking relationships and mainstream U.S. consumers. Brit

MarketBeat

CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push

CG Oncology (NASDAQ:CGON) is focused on advancing cretostimogene, an oncolytic immunotherapy for non-muscle invasive bladder cancer, Chief Executive Officer Arthur Kuan said during a discussion at the Jefferies Global Healthcare Conference in New York. Kuan said the company believes the therapy cou

MarketBeat

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference

Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creati

MarketBeat

These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?

MetLife, Globe Life, and Unum Group are hitting 52-week highs as P&C premiums decline, rewarding insurers with life, group benefits, and health exposure.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Celsius Plots Energy Drink Comeback as Alani, Rockstar Deals Reshape Growth

Celsius (NASDAQ:CELH) executives said the company is working through a major portfolio transition as it integrates Alani and Rockstar into its platform while repositioning the core Celsius brand for renewed growth. Speaking at an investor conference, Chairman and CEO John Fieldly described the comp

MarketBeat

3 Stocks Under $20 to Buy Before a Broader Market Rally

Market rotation into robotics, crypto infrastructure, AI data centers, and precious metals is creating opportunities in speculative stocks under $20, including SERV, BTBT, and CDE.

MarketBeat

Petco Faces Tough Competition, But Momentum Is Building

Petco Health and Wellness is becoming a comprehensive petcare services destination capable of competing with Chewy for market share.

MarketBeat

The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It

The housing lock-in effect is limiting existing home supply. These three homebuilder stocks could benefit if interest rates move lower

MarketBeat

3 ETFs For the Coming Genomics Revolution

Genomics companies are an exciting frontier in health care, and ETFs can help to diversify to control risk while positioning investors to benefit.

MarketBeat

The Energy Trade Is Bigger Than Oil Prices: 3 Stocks to Buy and 2 to Sell

U.S. rig counts are climbing for the first time in years. Here are three energy stocks to buy on the dip — and two names analysts say to avoid right now.

MarketBeat

CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies

CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant diagnostics, specialty oncology and digital workflow integration. John Hanna, chief executiv

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam

Bruker (NASDAQ:BRKR) is seeing stronger order momentum across several end markets, with semiconductor metrology, non-U.S. academic and government customers, and parts of its diagnostics business helping offset continued weakness in U.S. academic funding, a company representative said at a Jefferies

MarketBeat

Black Rock Coffee Bar Targets 1,000 Stores as Loyalty Fuels Growth Plan

Black Rock Coffee Bar (NASDAQ:BRCB) executives outlined the company’s growth strategy, store economics and competitive positioning during a William Blair consumer event, emphasizing plans to sustain rapid unit expansion while leaning on customer loyalty, store-level execution and a differentiated ca

MarketBeat

Backblaze Sees AI Boom Fueling Cloud Storage Demand and Neocloud Deals

Backblaze (NASDAQ:BLZE) Chief Executive Gleb Budman said the cloud storage company is seeing a material shift in demand tied to artificial intelligence workloads, as customers seek alternatives to hyperscaler platforms and newer AI-focused cloud providers look to add storage capabilities. Speaking

MarketBeat

Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?

Samsara 's delivered once again, but the stock has barely moved and there are reasons to think the market is underestimating its potential.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Blackbaud Touts AI Agents, Payments Growth and Buybacks at Baird Conference

Blackbaud (NASDAQ:BLKB) executives emphasized the company’s nonprofit software focus, artificial intelligence initiatives, payments opportunity and capital return strategy during a discussion hosted by Baird Senior Research Analyst Rob Oliver. Oliver described Blackbaud as a vertical software leade

MarketBeat

IREN's 800MW Bet Flips the AI Power Switch

IREN Limited is pivoting from Bitcoin mining to AI infrastructure, securing an 800MW data center campus in Australia and a $3.65 billion Microsoft-backed financing facility.

MarketBeat

BlackLine Says AI Agents, Platform Pricing Can Reignite Revenue Growth

BlackLine (NASDAQ:BL) executives said the company is leaning on platform pricing, artificial intelligence and deeper enterprise adoption as it works to reaccelerate revenue growth, according to remarks at a William Blair conference session. Chair and CEO Owen Ryan described BlackLine as a “mission-

MarketBeat

CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?

CrowdStrike stock fell after beating earnings and raising guidance. Here's why investors may see the post-earnings selloff as a buying opportunity

MarketBeat

Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test

U.S. EV sales fell 27% in Q1 2026 after federal tax credits ended, creating diverging outlooks for Rivian, Lucid, and Tesla amid continued global EV growth.

MarketBeat

From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading

Check out these three stocks that insiders are buying and selling, including giants in oil and AI, as well as a small gene stock seeing huge swings.

MarketBeat

BioAge Labs Eyes Key BGE-102 Readouts in Heart Risk and Diabetic Eye Disease

BioAge Labs (NASDAQ:BIOA) executives used a fireside chat at the Jefferies 2026 Global Healthcare Conference to outline the company’s plans for BGE-102, its lead NLRP3 inhibitor, with near-term readouts expected in cardiovascular risk and diabetic macular edema. The company’s chief business officer

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.